Latest news with #SSII
Time of India
21-07-2025
- Health
- Time of India
GMCH Nagpur Dean Performs India's First Public Sector Telesurgery From 1,A00km away
1 2 Nagpur: In a first-of-its-kind medical feat in the public healthcare system, Dr Raj Gajbhiye, eminent surgeon and dean of Government Medical College and Hospital (GMCH), performed two robotic surgeries from a distance of over 1,000km, while seated at a console in Gurugram. The historic procedures, carried out last week using the indigenously developed SSI Mantra Surgical Robotic System, mark India's first telesurgery in a govt hospital. The landmark operations — a hernia repair and a gallbladder removal — were performed by Dr Gajbhiye during his visit to the robotic facility in Gurugram. Despite the vast distance, both procedures were completed with flawless precision and minimal latency, thanks to the seamless integration of robotic technology and on-ground coordination by the surgical team in Nagpur. Dr Gajbhiye returned to Nagpur on Sunday after the successful demonstration. Calling the achievement a breakthrough for public health institutions in India, Dr Gajbhiye said, "This historic surgery sets a precedent for every govt medical institution in India. By successfully demonstrating telesurgery in a public setting, we are redefining the future of healthcare access and medical training. GMCH Nagpur is proud to lead this transformation in collaboration with SS Innovations International. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo " The SSI Mantra system, developed by Indian firm SSII, is the country's first and only indigenous robotic surgery platform. The success of this telesurgical procedure opens up new possibilities for delivering expert care to patients in remote or underserved areas — without the need for specialists to be physically present. "This is a defining moment for Indian healthcare," said Dr Sudhir Srivastava, founder and CEO of SSII. "Our vision is to make world-class surgical care accessible and affordable. With this collaboration with GMC Nagpur, the future of surgery has truly become borderless." This milestone reflects the growing role of indigenous innovation in bridging geographical barriers and democratising access to advanced surgical care, especially within India's public healthcare system. BOX How surgery was done - Dr Raj Gajbhiye operated on two patients in Nagpur while sitting at a robotic console in Gurugram - He performed a hernia and gallbladder surgery remotely - Surgeries were controlled in real time, with near-zero delay and full precision - His actions were relayed instantly to a robotic arm at GMCH Nagpur, guided by a support team - Technology allows expert surgeons to operate on patients in remote areas without being physically present - Reduces need for patients to travel long distances for complex surgeries
&w=3840&q=100)
Business Standard
25-04-2025
- Business
- Business Standard
SS Innovations lists on Nasdaq; shares trade under 'SSII' ticker
SS Innovations International, the India-based manufacturer of indigenous surgical robotic systems, announced that it has listed on the United States (US) Nasdaq. The trading commences on April 25, with the company's shares listed under the ticker symbol 'SSII'. The manufacturer of robotic assistance systems (RAS) expects the move will help in expanding its operations in the US, with SSII's robotic systems currently undergoing US Food and Drug Administration (USFDA) inspection. Sudhir Srivastava, chairman of the board and chief executive officer of SS Innovations, said that the timing of SSII's uplisting coincides with its global expansion beyond India into multiple countries worldwide. 'We are pursuing the European Union (EU)'s CE Mark and USFDA approval for our SSI Mantra surgical robotic system, which we expect to receive in late 2025 and early 2026, respectively,' he said. Srivastava added that the uplisting to Nasdaq will enhance market awareness of its story, improve transparency, expand their potential investor base, and ultimately increase share liquidity. The company stated that it has reported a 3.5-fold year-on-year increase in its revenue for the year ending December 31, 2024, at $20.6 million, compared to $5.9 million reported in the previous corresponding period. 'Gross margins also showed significant improvement, rising to 40.9 per cent from 12.3 per cent in 2023, highlighting the company's robust financial performance and expanding market presence,' the company said. Srivastava added the company is looking at an advantage in the US market through its affordability factor. 'In the US, the latest robotic system sells between $2.5 million to $3 million. Even with us exporting systems from India to the US, it will cost somewhere around $1.2 million at the most,' he added. SSII adds that its surgical robotic systems have been installed in 80 hospitals across 75 locations in India. The company is also planning to expand its footprint to other countries including Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, and Ukraine. With over 3,700 procedures performed using the SSI Mantra, which includes more than 200 robotic cardiac procedures, Srivastava said that the system has zero reported device-related mortality, injuries, or complications.
